Literature DB >> 17825047

Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles.

Ian Holt1, Saloni Mittal, Denis Furling, Gillian S Butler-Browne, J David Brook, Glenn E Morris.   

Abstract

Nuclear speckles are storage sites for small nuclear RNPs (snRNPs) and other splicing factors. Current ideas about the role of speckles suggest that some pre-mRNAs are processed at the speckle periphery before being exported as mRNA. In myotonic dystrophy type 1 (DM1), the export of mutant DMPK mRNA is prevented by the presence of expanded CUG repeats that accumulate in nuclear foci. We now show that these foci accumulate at the periphery of nuclear speckles. In myotonic dystrophy type 2 (DM2), mRNA from the mutant ZNF9 gene is exported normally because the expanded CCUG repeats are removed during splicing. We now show that the nuclear foci formed by DM2 intronic repeats are widely dispersed in the nucleoplasm and not associated with either nuclear speckles or exosomes. We hypothesize that the expanded CUG repeats in DMPK mRNA are blocking a stage in its export pathway that would normally occur at the speckle periphery. Localization of the expanded repeats at the speckle periphery is not essential for their pathogenic effects because DM1 and DM2 are quite similar clinically.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17825047     DOI: 10.1111/j.1365-2443.2007.01112.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  44 in total

1.  mRNA nuclear export and human disease.

Authors:  Jessica A Hurt; Pamela A Silver
Journal:  Dis Model Mech       Date:  2008 Sep-Oct       Impact factor: 5.758

2.  Assembly and mobility of exon-exon junction complexes in living cells.

Authors:  Ute Schmidt; Kang-Bin Im; Carola Benzing; Snjezana Janjetovic; Karsten Rippe; Peter Lichter; Malte Wachsmuth
Journal:  RNA       Date:  2009-03-26       Impact factor: 4.942

Review 3.  The dynamic pathway of nuclear RNA in eukaryotes.

Authors:  Jonathan Sheinberger; Yaron Shav-Tal
Journal:  Nucleus       Date:  2013-04-11       Impact factor: 4.197

4.  Macrocyclization of a Ligand Targeting a Toxic RNA Dramatically Improves Potency.

Authors:  Raphael I Benhamou; Simon Vezina-Dawod; Shruti Choudhary; Kye Won Wang; Samantha M Meyer; Ilyas Yildirim; Matthew D Disney
Journal:  Chembiochem       Date:  2020-08-26       Impact factor: 3.164

5.  Biological Efficacy and Toxicity of Diamidines in Myotonic Dystrophy Type 1 Models.

Authors:  Ruth B Siboni; Micah J Bodner; Muhammad M Khalifa; Aaron G Docter; Jessica Y Choi; Masayuki Nakamori; Michael M Haley; J Andrew Berglund
Journal:  J Med Chem       Date:  2015-07-21       Impact factor: 7.446

6.  Actinomycin D Specifically Reduces Expanded CUG Repeat RNA in Myotonic Dystrophy Models.

Authors:  Ruth B Siboni; Masayuki Nakamori; Stacey D Wagner; Adam J Struck; Leslie A Coonrod; Shanee A Harriott; Daniel M Cass; Matthew K Tanner; J Andrew Berglund
Journal:  Cell Rep       Date:  2015-12-10       Impact factor: 9.423

7.  Precise small-molecule recognition of a toxic CUG RNA repeat expansion.

Authors:  Suzanne G Rzuczek; Lesley A Colgan; Yoshio Nakai; Michael D Cameron; Denis Furling; Ryohei Yasuda; Matthew D Disney
Journal:  Nat Chem Biol       Date:  2016-12-12       Impact factor: 15.040

8.  Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms.

Authors:  Benedikt Schoser; Lubov Timchenko
Journal:  Curr Genomics       Date:  2010-04       Impact factor: 2.236

9.  Hsp70 gene association with nuclear speckles is Hsp70 promoter specific.

Authors:  Yan Hu; Matt Plutz; Andrew S Belmont
Journal:  J Cell Biol       Date:  2010-11-08       Impact factor: 10.539

10.  Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle.

Authors:  Ian Holt; Virginie Jacquemin; Majid Fardaei; Caroline A Sewry; Gillian S Butler-Browne; Denis Furling; J David Brook; Glenn E Morris
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.